Iguratimod suppresses sclerostin and receptor activator of NF-κB ligand production via the extracellular signal–regulated kinase/early growth response protein 1/tumor necrosis factor alpha pathway in osteocytes and ameliorates disuse osteoporosis in mice-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Iguratimod suppresses sclerostin and receptor activator of NF-κB ligand production via the extracellular signal–regulated kinase/early growth response protein 1/tumor necrosis factor alpha pathway in osteocytes and ameliorates disuse osteoporosis in mice

Published:2024-02 Issue: Volume: Page:117026
ISSN:8756-3282
Container-title:Bone
language:en
Short-container-title:Bone

Author:

Miura Taihei,Etani Yuki,Noguchi Takaaki,Hirao Makoto,Takami Kenji,Goshima Atsushi,Kurihara Takuya,Fukuda Yuji,Ochiai Nagahiro,Kanamoto Takashi,Nakata Ken,Okada Seiji,Ebina Kosuke^ORCID

Publisher

Elsevier BV

Subject

Histology,Physiology,Endocrinology, Diabetes and Metabolism

Reference50 articles.

1. The osteocyte as a signaling cell;Delgado-Calle;Physiol. Rev.,2022

2. The amazing osteocyte;Bonewald;J. Bone Miner. Res.,2011

3. Mechanical regulation of bone remodeling;Wang;Bone Res,2022

4. The current state of bone loss research: data from spaceflight and microgravity simulators;Nagaraja;J. Cell. Biochem.,2013

5. Early effects of IL-6 receptor inhibition on bone homeostasis: a pilot study in women with rheumatoid arthritis;Terpos;Clin. Exp. Rheumatol.,2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP